Literature DB >> 3325324

Counterregulation in type 2 (non-insulin-dependent) diabetes mellitus. Normal endocrine and glycaemic responses, up to ten years after diagnosis.

S R Heller1, I A Macdonald, R B Tattersall.   

Abstract

We have examined hormonal and metabolic responses to insulin-induced hypoglycaemia in 10 Type 2 (non-insulin-dependent) diabetic patients treated with tablets and 10 age, sex and weight matched control subjects. Diabetic patients were under 110% ideal body weight, had no autonomic neuropathy and were well controlled (HbA1, 7.1 +/- 0.2%). After the diabetic patients were kept euglycaemic by an overnight insulin infusion, hypoglycaemia was induced in both groups by intravenous insulin at 30 mU.m-2.min-1 for 60 min and counterregulatory responses measured for 150 min. There were no significant differences between diabetic patients and control subjects in the rate of fall (3.3 +/- 0.3 vs 4.0 +/- 0.3 mmol.l-1.h-1), nadir (2.4 +/- 0.2 vs 2.3 +/- 0.1 mmol/l) and rate of recovery (0.027 +/- 0.002 vs 0.030 +/- 0.003 mmol.l-1.min-1) of blood glucose. Increments of glucagon (60.5 +/- 5.7 vs 70 +/- 9.2 ng/l) and adrenaline (1.22 +/- 0.31 vs 1.45 +/- 0.31 nmol/l) were similar in both groups. When tested using this model, patients with Type 2 diabetes, without microvascular complications and taking oral hypoglycaemic agents show no impairment of the endocrine response and blood glucose recovery following hypoglycaemia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3325324     DOI: 10.1007/bf00295875

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  31 in total

1.  Intraislet negative insulin-glucagon feedback.

Authors:  E Samols; J Harrison
Journal:  Metabolism       Date:  1976-11       Impact factor: 8.694

2.  Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epinephrine in humans.

Authors:  M A Berk; W E Clutter; D Skor; S D Shah; R P Gingerich; C A Parvin; P E Cryer
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

3.  Glucose counterregulation in patients after pancreatectomy. Comparison with other clinical forms of diabetes.

Authors:  K S Polonsky; K C Herold; J L Gilden; R M Bergenstal; V S Fang; A R Moossa; J B Jaspan
Journal:  Diabetes       Date:  1984-11       Impact factor: 9.461

4.  Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions.

Authors:  G B Bolli; E Tsalikian; M W Haymond; P E Cryer; J E Gerich
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

5.  A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus.

Authors:  G B Bolli; P De Feo; S De Cosmo; G Perriello; M M Ventura; M M Benedetti; F Santeusanio; J E Gerich; P Brunetti
Journal:  Diabetes       Date:  1984-08       Impact factor: 9.461

6.  Defective blood glucose counter-regulation in diabetics is a selective form of autonomic neuropathy.

Authors:  L V Campbell; E W Kraegen; L Lazarus
Journal:  Br Med J       Date:  1977-12-10

7.  Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia.

Authors:  G Bolli; P De Feo; G Perriello; S De Cosmo; P Compagnucci; F Santeusanio; P Brunetti; R H Unger
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

8.  Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy.

Authors:  N H White; D A Skor; P E Cryer; L A Levandoski; D M Bier; J V Santiago
Journal:  N Engl J Med       Date:  1983-03-03       Impact factor: 91.245

9.  Radioimmunoassay for pancreatic polypeptide, and its age-related changes in concentration.

Authors:  M M O'Hare; J G Daly; K D Buchanan
Journal:  Clin Chem       Date:  1983-11       Impact factor: 8.327

10.  Counterregulatory hormone release and glucose recovery after hypoglycemia in non-insulin-dependent diabetic patients.

Authors:  G Boden; M Soriano; R D Hoeldtke; O E Owen
Journal:  Diabetes       Date:  1983-11       Impact factor: 9.461

View more
  9 in total

1.  Adaptation to mild hypoglycaemia in normal subjects despite sustained increases in counter-regulatory hormones.

Authors:  D Kerr; I A Macdonald; R B Tattersall
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

Review 2.  Neuroendocrine responses to hypoglycemia.

Authors:  Nolawit Tesfaye; Elizabeth R Seaquist
Journal:  Ann N Y Acad Sci       Date:  2010-10-29       Impact factor: 5.691

Review 3.  Alpha cell function in health and disease: influence of glucagon-like peptide-1.

Authors:  B E Dunning; J E Foley; B Ahrén
Journal:  Diabetologia       Date:  2005-08-13       Impact factor: 10.122

Review 4.  Adverse effects of exogenous insulin. Clinical features, management and prevention.

Authors:  A W Patrick; G Williams
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

Review 5.  Early sympathetic islet neuropathy in autoimmune diabetes: lessons learned and opportunities for investigation.

Authors:  Thomas O Mundinger; Gerald J Taborsky
Journal:  Diabetologia       Date:  2016-06-24       Impact factor: 10.122

6.  Hormonal counterregulation and consecutive glimepiride serum concentrations during severe hypoglycaemia associated with glimepiride therapy.

Authors:  A Holstein; A Plaschke; C Hammer; M Ptak; J Kuhn; C Kratzsch; J Diekmann; K Kleesiek; H H Maurer; E-H Egberts
Journal:  Eur J Clin Pharmacol       Date:  2003-11-22       Impact factor: 2.953

Review 7.  Non-insulin-dependent (type II) diabetes mellitus.

Authors:  W Rodger
Journal:  CMAJ       Date:  1991-12-15       Impact factor: 8.262

8.  Impact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes.

Authors:  Yingnan Zhao; Claudia R Campbell; Vivian Fonseca; Lizheng Shi
Journal:  Diabetes Care       Date:  2012-03-19       Impact factor: 19.112

9.  Human Type 1 Diabetes Is Characterized by an Early, Marked, Sustained, and Islet-Selective Loss of Sympathetic Nerves.

Authors:  Thomas O Mundinger; Qi Mei; Alan K Foulis; Corinne L Fligner; Rebecca L Hull; Gerald J Taborsky
Journal:  Diabetes       Date:  2016-05-13       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.